EA201790091A1 - Лечение тяжелой гипертриглицеридемии - Google Patents
Лечение тяжелой гипертриглицеридемииInfo
- Publication number
- EA201790091A1 EA201790091A1 EA201790091A EA201790091A EA201790091A1 EA 201790091 A1 EA201790091 A1 EA 201790091A1 EA 201790091 A EA201790091 A EA 201790091A EA 201790091 A EA201790091 A EA 201790091A EA 201790091 A1 EA201790091 A1 EA 201790091A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- hypertrigliceridemia
- heavy
- mbh
- type
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462017444P | 2014-06-26 | 2014-06-26 | |
| PCT/US2015/037596 WO2015200580A1 (en) | 2014-06-26 | 2015-06-25 | Treatment of severe hypertriglyceridemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201790091A1 true EA201790091A1 (ru) | 2017-07-31 |
Family
ID=53511030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201790091A EA201790091A1 (ru) | 2014-06-26 | 2015-06-25 | Лечение тяжелой гипертриглицеридемии |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20150374649A1 (enExample) |
| EP (1) | EP3160458A1 (enExample) |
| JP (1) | JP2017519028A (enExample) |
| KR (1) | KR20170020514A (enExample) |
| CN (1) | CN106470675A (enExample) |
| AU (1) | AU2015279905A1 (enExample) |
| BR (1) | BR112016028918A2 (enExample) |
| CA (1) | CA2951280A1 (enExample) |
| CL (1) | CL2016003290A1 (enExample) |
| EA (1) | EA201790091A1 (enExample) |
| HK (1) | HK1231380A1 (enExample) |
| IL (1) | IL249757A0 (enExample) |
| MX (1) | MX2016017081A (enExample) |
| PH (1) | PH12016502415A1 (enExample) |
| SG (1) | SG11201610243YA (enExample) |
| WO (1) | WO2015200580A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10272058B2 (en) | 2014-03-20 | 2019-04-30 | Cymabay Therapeutics, Inc. | Treatment of intrahepatic cholestatic diseases |
| ES2701094T3 (es) | 2014-03-20 | 2019-02-20 | Cymabay Therapeutics Inc | Tratamiento de enfermedades colestáticas intrahepáticas |
| CA2944139C (en) | 2014-04-11 | 2020-11-03 | Cymabay Therapeutics, Inc. | Treatment of nafld and nash |
| US10512622B2 (en) | 2017-07-14 | 2019-12-24 | Cymabay Therapeutics, Inc. | Treatment of intrahepatic cholestatic diseases |
| CA3085951C (en) * | 2017-12-21 | 2022-10-11 | Kowa Company, Ltd. | Methods of treatment of hypertriglyceridemia |
| US20210145774A1 (en) | 2019-11-14 | 2021-05-20 | Cymabay Therapeutics, Inc. | Treatment of alcoholic liver disease |
| WO2021097034A1 (en) | 2019-11-14 | 2021-05-20 | Cymabay Therapeutics, Inc. | Seladelpar for use in the treatment of intestinal barrier dysfunction and associated diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA87467C2 (xx) | 2003-09-19 | 2009-07-27 | Янссен Фармацевтика Н.В | 4-((феноксіалкіл)тіо)феноксіоцтова кислота та її аналоги$4-((феноксиалкил)тио)феноксиуксусная кислота и ее аналоги |
| JO3006B1 (ar) | 2005-09-14 | 2016-09-05 | Janssen Pharmaceutica Nv | املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك |
| SG183529A1 (en) * | 2010-03-30 | 2012-10-30 | Novartis Ag | Uses of dgat1 inhibitors |
-
2015
- 2015-06-25 CN CN201580033722.XA patent/CN106470675A/zh active Pending
- 2015-06-25 EA EA201790091A patent/EA201790091A1/ru unknown
- 2015-06-25 KR KR1020177002016A patent/KR20170020514A/ko not_active Withdrawn
- 2015-06-25 US US14/749,934 patent/US20150374649A1/en not_active Abandoned
- 2015-06-25 JP JP2016575073A patent/JP2017519028A/ja not_active Withdrawn
- 2015-06-25 EP EP15734013.4A patent/EP3160458A1/en not_active Withdrawn
- 2015-06-25 BR BR112016028918A patent/BR112016028918A2/pt not_active Application Discontinuation
- 2015-06-25 CA CA2951280A patent/CA2951280A1/en not_active Abandoned
- 2015-06-25 WO PCT/US2015/037596 patent/WO2015200580A1/en not_active Ceased
- 2015-06-25 SG SG11201610243YA patent/SG11201610243YA/en unknown
- 2015-06-25 HK HK17105013.3A patent/HK1231380A1/zh unknown
- 2015-06-25 MX MX2016017081A patent/MX2016017081A/es unknown
- 2015-06-25 AU AU2015279905A patent/AU2015279905A1/en not_active Abandoned
-
2016
- 2016-12-02 PH PH12016502415A patent/PH12016502415A1/en unknown
- 2016-12-22 CL CL2016003290A patent/CL2016003290A1/es unknown
- 2016-12-25 IL IL249757A patent/IL249757A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2016017081A (es) | 2017-05-01 |
| CL2016003290A1 (es) | 2017-09-08 |
| PH12016502415A1 (en) | 2017-02-27 |
| EP3160458A1 (en) | 2017-05-03 |
| SG11201610243YA (en) | 2017-01-27 |
| IL249757A0 (en) | 2017-02-28 |
| CN106470675A (zh) | 2017-03-01 |
| WO2015200580A1 (en) | 2015-12-30 |
| BR112016028918A2 (pt) | 2017-08-22 |
| AU2015279905A1 (en) | 2017-02-02 |
| JP2017519028A (ja) | 2017-07-13 |
| KR20170020514A (ko) | 2017-02-22 |
| CA2951280A1 (en) | 2015-12-30 |
| US20150374649A1 (en) | 2015-12-31 |
| HK1231380A1 (zh) | 2017-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL257978B (en) | Use of pasteurized akkermansia for treating metabolic disorders | |
| MX381640B (es) | Metodos y compuestos agonistas de gip. | |
| EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
| EA201790737A1 (ru) | Комбинированная терапия | |
| EA201691582A1 (ru) | Новые фармацевтические препараты | |
| MA41028A (fr) | Méthodes et formulations pour le traitement de pathologies oculaires vasculaires | |
| EP3960735C0 (en) | QUINAZOLINE DERIVATIVES USED TO TREAT HIV | |
| EP3875139C0 (en) | TREATMENT OF VENOUS DISEASES | |
| DE102015009910A8 (de) | Automatische Aggregation von Online-Benutzerprofilen | |
| EA201791029A1 (ru) | Антитела против интерлейкина-33 и их применение | |
| EA201790785A1 (ru) | Производные тетрагидроизохинолина | |
| EA201600589A1 (ru) | Ингибиторы диацилглицеринацилтрансферазы 2 для применения в лечении метаболических и связанных с метаболизмом расстройств | |
| EA201691610A8 (ru) | Анти-jagged1 антитела и способы применения | |
| PH12016502415A1 (en) | Treatment of severe hypertriglyceridemia | |
| DK3229840T5 (da) | 3,5-dihydroxy-4-isopropyl-trans-stilben til anvendelse i topisk behandling af akne | |
| EP3209331C0 (en) | OPHTHALMIC SOLUTION | |
| MX2016009590A (es) | Composiciones de apilimod y métodos para usar las mismas. | |
| EA201890810A1 (ru) | Соединения, эффективные для лечения гепатотоксичности и стеатоза печени, и их применение | |
| CU24407B1 (es) | Moduladores de pirrolopiridina de rorc2 sustituidos con metilo y trifluorometilo | |
| EA201791467A1 (ru) | Водный офтальмологический раствор | |
| LT3297653T (lt) | Postbariatrinės hipoglikemijos gydymas glp-1 antagonistais | |
| MX377593B (es) | Composiciones para usar en el tratamiento de cáncer renal. | |
| EA201890776A1 (ru) | Агонисты ppar, соединения, фармацевтические композиции и способы их применения | |
| EA201691887A1 (ru) | Лечение внутрипеченочных холестатических заболеваний | |
| EA201591399A1 (ru) | РАППγ АГОНИСТЫ ДЛЯ ЛЕЧЕНИЯ РАССЕЯННОГО СКЛЕРОЗА |